Markets by TradingView

Browsing Tag

Multiple Sclerosis Treatment

3 posts

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

Nets CAD$15,480,780 cash in non-dilutive capital Current cash position of approximately CAD$50…

FSD Pharma Appoints Julia Levy Award Recipient David Allan and Dr. John McGraw to Advisory Board

Mr. Allan, the 2017 winner of the prestigious Julia Levy Award, to…

FSD Pharma’s Team Advancing a New Approach to Multiple Sclerosis

Multiple sclerosis, or MS, is a degenerative neurological disorder that makes life…